Combined CDK2 and CDK4/6 Inhibition Overcomes Palbociclib Resistance in Breast Cancer by Enhancing Senescence.

Pandey, Kamal; Park, Nahee; Park, Kyung-Soon; Hur, Jin; Cho, Yong Bin; Kang, Minsil; An, Hee-Jung; Kim, Sewha; Hwang, Sohyun; Moon, Yong Wha

Pandey, Kamal; Park, Nahee; Park, Kyung-Soon; Hur, Jin; Cho, Yong Bin; Kang, Minsil; An, Hee-Jung; Kim, Sewha; Hwang, Sohyun; Moon, Yong Wha.

Afiliação

Pandey K; Hematology and Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam 13488, Korea.
Park N; Department of Biomedical Science, CHA University, Seongnam 13488, Korea.
Park KS; Hematology and Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam 13488, Korea.
Hur J; Department of Biomedical Science, CHA University, Seongnam 13488, Korea.
Cho YB; Hematology and Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam 13488, Korea.
Kang M; Department of Biomedical Science, CHA University, Seongnam 13488, Korea.
An HJ; Hematology and Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam 13488, Korea.
Kim S; Hematology and Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam 13488, Korea.
Hwang S; Department of Pathology, CHA Bundang Medical Center, CHA University, Seongnam 13488, Korea.
Moon YW; Department of Pathology, CHA Bundang Medical Center, CHA University, Seongnam 13488, Korea.

Cancers (Basel) ; 12(12)2020 Nov 29.

Article em En | MEDLINE | ID: mdl-33260316

Palavras-chave

C-MYC; CDK2; CDK4/6; drug resistance; hormone receptor-positive breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google